Prospective Biomarkers of Bone Metabolism in Hemophilia A

计划入组 16 人 · 首次发布于 2014 年 12 月 3 日

Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A

计划入组 15 人 · 首次发布于 2014 年 11 月 4 日

A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)

计划入组 20 人 · 首次发布于 2025 年 8 月 19 日

MDM2 inhibitors(Adamed Group)

IOLs (AffaMed Therapeutics)

Adamed Pharma S.A.

Poland

Andramed GmbH

Germany

ADVANCED BIONICS

France

Moores Cancer Center Accelerates Clinical Trial Activation, Improving Patient Access to Novel Therapies

CMS Proposes to Eliminate Alternative Payment Pathway for Breakthrough Medical Devices

Healthcare Coalition Urges CMS to Accelerate Medicare Coverage for Breakthrough Medical Devices